Dashboard
Manage Tickers

ABVX Abivax S.A.

Nasdaq www.abivax.com


$ 102.88 $ -1.87 (-1.79 %)    

Friday, 31-Oct-2025 19:02:29 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 629.16 $ 3.02 (0.48 %)
DIA $ 475.58 $ 0.66 (0.14 %)
SPY $ 681.80 $ 2.23 (0.33 %)
TLT $ 90.21 $ -0.27 (-0.3 %)
GLD $ 368.20 $ -2.01 (-0.54 %)
$ 102.42
$ 106.09
$ 98.00 x 101
$ 102.88 x 46
$ 102.41 - $ 108.00
$ 4.77 - $ 108.00
897,684
na
6.46B
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

barclays-initiates-coverage-on-abivax-with-overweight-rating-announces-price-target-of-142
Barclays Initiates Coverage On Abivax with...
10/13/2025 11:58:56

Barclays analyst Etzer Darout initiates coverage on Abivax (NASDAQ:ABVX) with a Overweight rating and announces Price Target...

guggenheim-maintains-buy-on-abivax-raises-price-target-to-150
Guggenheim Maintains Buy on Abivax, Raises...
10/10/2025 12:36:10

Guggenheim analyst Yatin Suneja maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price target from $101 to $150.

tilray-brands-posts-upbeat-results-joins-byrna-technologies-delta-air-lines-and-other-big-stocks-moving-higher-on-thursday
Tilray Brands Posts Upbeat Results, Joins ...
10/09/2025 14:14:52

amd-to-rally-more-than-47-here-are-10-top-analyst-forecasts-for-tuesday
AMD To Rally More Than 47%? Here Are 10 To...
10/07/2025 12:13:15

btig-maintains-buy-on-abivax-raises-price-target-to-120
BTIG Maintains Buy on Abivax, Raises Price...
10/07/2025 09:56:29

BTIG analyst Julian Harrison maintains Abivax (NASDAQ:ABVX) with a Buy and raises the price target from $112 to $120.

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/06/2025 17:35:26

why-is-abivax-stock-trading-higher-on-monday
Why Is Abivax Stock Trading Higher On Monday?
10/06/2025 15:05:40

Abivax said Phase 3 trials showed obefazimod improved clinical outcomes in ulcerative colitis, meeting key endpoints with no ne...

Core News & Articles
Abivax Drug Obefazimod Shows Results In Ph...
10/06/2025 08:07:24

Abivax SA (PARIS:FR, NASDAQ:ABVX) ("Abivax" or the "Company"), a clinical-stage biotechnology company focused o...

reported-sunday-abivax-announces-late-breaking-phase-3-data-showing-obefazimod-achieved-164-placebo-adjusted-remission-rate-at-week-8-in-ulcerative-colitis
Reported Sunday, Abivax Announces Late-Bre...
10/06/2025 06:32:05

50 mg once-daily dose of obefazimod led to a pooled 16.4% (p<0.0001) placebo-adjusted clinical remission rate at Week 8; met...

Core News & Articles
Abivax SA Will Present Second Late-breakin...
09/29/2025 20:10:13

Late Breaking Abstract titled EFFICACY AND SAFETY OF OBEFAZIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLIT...

jmp-securities-maintains-market-outperform-on-abivax-raises-price-target-to-114
JMP Securities Maintains Market Outperform...
09/25/2025 13:06:37

JMP Securities analyst Jason N. Butler maintains Abivax (NASDAQ: ABVX) with a Market Outperform and raises the price target ...

Core News & Articles
AbivaxTo Present Late-Breaking Abstract f...
09/23/2025 20:09:36

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United ...

morgan-stanley-maintains-overweight-on-abivax-raises-price-target-to-101
Morgan Stanley Maintains Overweight on Abi...
09/12/2025 15:37:21

Morgan Stanley analyst Judah Frommer maintains Abivax (NASDAQ:ABVX) with a Overweight and raises the price target from $71 t...

rh-posts-downbeat-results-joins-frequency-electronics-tronox-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
RH Posts Downbeat Results, Joins Frequency...
09/12/2025 12:24:19

btig-reiterates-buy-on-abivax-maintains-112-price-target
BTIG Reiterates Buy on Abivax, Maintains $...
09/09/2025 11:15:54

BTIG analyst Julian Harrison reiterates Abivax (NASDAQ:ABVX) with a Buy and maintains $112 price target.

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

earnings-outlook-for-abivax
Earnings Outlook For Abivax
08/08/2025 15:01:14

piper-sandler-maintains-overweight-on-abivax-raises-price-target-to-112
Piper Sandler Maintains Overweight on Abiv...
07/29/2025 11:43:03

Piper Sandler analyst Allison Bratzel maintains Abivax (NASDAQ:ABVX) with a Overweight and raises the price target from $70 ...

intel-absci-ast-spacemobile-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
Intel, Absci, AST SpaceMobile And Other Bi...
07/25/2025 12:34:46

abivax-offering-closes-at-7475m-as-underwriters-take-full-option-net-proceeds-estimated-at-7003m-to-support-inflammation-drug-pipeline
Abivax Offering Closes At $747.5M As Under...
07/25/2025 06:23:15

Abivax Announces Full Exercise of Underwriters' Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION